Healthcare Industry News:  Royal Philips 

Devices Monitoring

 News Release - October 24, 2006

Philips Announces Availability of Triplets Monitoring with Its Avalon Fetal Monitors; Company is first to introduce triplets monitoring using one fetal monitor

ANDOVER, Mass.--(HSMN NewsFeed)--Royal Philips (NYSE: PHG, AEX: PHI) today announced the availability of triplets monitoring functionality for its industry-leading line of obstetrical care fetal and maternal monitors, Avalon FM20 antepartum and Avalon FM30 intrapartum. Philips is the first company to introduce a fetal monitor that enables non-invasive triplets monitoring with a single device.

High-risk pregnancies with multiples require vigilant obstetrical care. Their incidence is rising due to older mothers and the use of fertility therapies. In the last two decades the number of higher order multiples births (triplets or more) in the U.S. has increased substantially, according to the National Center for Health Statistics. Recognizing this growing need, Philips has extended its advanced ultrasound fetal monitoring technology to enable triplets monitoring.

"With the worldwide increase in the birth rate for triplets, we're pleased to pioneer non-invasive triplets monitoring in a single monitor," said David Russell, vice president of global marketing, patient monitoring, for Philips Medical Systems. "Triplets monitoring is yet another example of our long-standing commitment to developing sophisticated, advanced obstetrical care products for clinicians and patients that are accurate, reliable and extremely intuitive to operate."

Built on Philips industry-leading IntelliVue patient monitoring platform, Avalon FM20 antepartum monitors and Avalon FM30 intrapartum monitors use three channels of high-quality ultrasound tracing and check coincidence between the heart rates of the mother and all fetuses to help ensure each fetus is being monitored. The monitor displays the three fetal heart rates, along with the mother's heart rate, on a color touchscreen.

Two features help clinicians sort out multiple fetal heart traces. Trace Separation was pioneered by Philips for twins monitoring and has now been expanded for triplets monitoring with the new Avalon FM20 and FM30 monitors. Trace Separation allows users to stack multiple traces along the vertical scale, which adjusts to ensure the traces can be read clearly. Users can also assign a different line thickness to each fetal heart rate trace.

The Transducer Finder feature identifies which transducer is monitoring each heart rate. When a user selects any fetal heart rate on the monitor display, the corresponding transducer lights up.

Both Avalon FM20 and FM30 track maternal blood pressure, pulse and uterine activity. The Avalon FM30 also monitors maternal SpO2 and ECG. It covers patients from the onset of contractions through the final stages of delivery with its full set of external and internal fetal parameters, such as ultrasound and direct fetal heart rate, toco and intrauterine pressure.

Data from the monitors can be automatically transmitted to the Philips OB TraceVue obstetrical information system for comprehensive information management across the obstetrical care continuum, from the beginning of pregnancy through postpartum visits, as well as across multiple pregnancies.

Philips Medical Systems has a history of pioneering obstetrical care products, dating back to the company's Hewlett-Packard roots. In 1968, the company introduced the first non-invasive fetal monitor. Since then, obstetrical care teams have used Philips care solutions in hospital labor and delivery departments, offices and homes. Innovations like cordless transducers, twins and triplets monitoring, and cross-channel verification technology have positioned Philips as a leader in the obstetrical care market.

About Royal Philips Electronics

Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a global leader in healthcare, lifestyle and technology, delivering products, services and solutions through the brand promise of "sense and simplicity." Headquartered in the Netherlands, Philips employs approximately 126,000 employees in more than 60 countries worldwide. With sales of $37.7 billion (EUR 30.4 billion) in 2005, the company is a market leader in medical diagnostic imaging and patient monitoring systems, energy efficient lighting solutions, personal care and home appliances, as well as consumer electronics. News from Philips is located at

Source: Royal Philips

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.